Navigation Links
The Global Cardiovascular Drugs Market to Decline at a CAGR of 10.47 Percent Over the Period 2012-2016
Date:8/8/2013

DUBLIN, August 8, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/f5rg4j/global) has announced the addition of the "Global Cardiovascular Drugs Market 2012-2016" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

One of the key factors affecting market growth is the over-dependency of the market on the US. The Global Cardiovascular Drugs market has also been witnessing an increase in R&D activities. However, the increase in healthcare expenditure could be one of the factors that will contribute to the growth of this market.

The key vendors dominating this market space are AstraZeneca plc, Bristol-Myers Squibb Co., Merck & Co. Inc., Novartis AG, Pfizer Inc., and Sanofi.

The other vendors mentioned in the report are Abbott Laboratories, Forest Laboratories Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Daiichi Sankyo Co. Ltd., GlaxoSmithKline plc, Solvay SA, Takeda Pharmaceutical Co. Ltd., and The Medicines Co.

Commenting on the report, an analyst from TechNavio's Healthcare team said: "In the last few years, the Healthcare industry has witnessed phenomenal growth in the APAC region. Emerging economies such as the APAC region, Eastern Europe, and Latin America hold vast growth potential. These regions are under-equipped to address the increase in the incidence of CVDs in the region. However, the increase in the incidence of CVDs and instances of patients frequently enduring long waits for therapeutic treatments are forcing healthcare organizations in the region to opt for cardiovascular drugs. Moreover, there has been substantial investment to initiate a significant number of projects in R&D across the developing countries. Hence, healthcare organizations in developing regions such as the APAC region and the Middle East are opting for cardiovascular drugs in accordance with the demand in specific countries. The increasing demand for cardiovascular drugs in the developing countries is boosting the growth of the global cardiovascular drugs market."

Companies Mentioned

- AstraZeneca plc
- Bristol-Myers Squibb Co.
- Merck & Co. Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi.
- Abbott Laboratories
- Forest Laboratories Inc.
- F. Hoffmann-La Roche Ltd.
- Bayer AG
- Daiichi Sankyo Co. Ltd.
- GlaxoSmithKline plc
- Solvay SA
- Takeda Pharmaceutical Co. Ltd.
- The Medicines Co.

For more information visit http://www.researchandmarkets.com/research/f5rg4j/global

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Cardiovascular Devices

 


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Top buyers including Atico, Coles Group Asia, Kmart, Staples, Office Depot and Target Australia pre-registered to attend Global Sources spring China Sourcing Fairs
2. ConvaTec Donates $10,000 To AAWC Global Volunteers Program Through SAWC Walk For Wellness
3. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
4. Attendees Save Up To $800 on Global Healthcare Conferences in 2012 by Registering Through Global Information Inc.
5. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
6. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
7. Ultra Clean to Present at the Jefferies 2012 Global Technology, Media & Telcom Conference
8. Axis Global Logistics Names Mr. Thomas Brennan, Vice President Strategic Accounts & Life Sciences
9. Angeion Appoints Matthew S. Margolies as Executive Vice President - Global Sales
10. OTC Pharmaceuticals: Global Industry Almanac, MarketLine
11. Global Pharmaceutical Leaders All Converging in Parsippany, New Jersey on September 11-12, 2012 for Breakthrough Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2017)... 2017 Three Tru-D SmartUVC robots have arrived at ... . Tru-D, short for "Total Room Ultraviolet Disinfection," is a 5-foot-5 ... environmental services (ES) professional cleans the area with traditional cleaning protocols. ... Tru-D fights germs at ... "Although the BAACH has a very low ...
(Date:7/28/2017)... CHICAGO, July 28, 2017 Hill-Rom Holdings, Inc. ... fiscal third quarter ended June 30, 2017, and updated ... For the fiscal third quarter, ... to $0.68 per diluted share in the prior-year period. ... of $0.39 per diluted share primarily related to the ...
(Date:7/27/2017)... Ind., July 27, 2017  Zimmer Biomet Holdings, Inc. ... quarter ended June 30, 2017.  The Company reported second ... 1.1% over the prior year period, and an increase ... 240 basis points of contribution from the LDR Holding ... the second quarter of 2016, or 0.3% on a ...
Breaking Medicine Technology:
(Date:8/22/2017)... ... August 22, 2017 , ... The Women’s Choice Award, a growing platform that ... the 2017 Women’s Choice Award. The identification by women of an effective new ... migraine sufferers are women. In a survey taken by the Women’s Choice Award organization, ...
(Date:8/22/2017)... ... August 22, 2017 , ... GeBBS Healthcare Solutions, a leading ... a new professional fee E/M leveling calculator tool. The new resource is offered ... E/M coding is complex which supports the need for a tool of this ...
(Date:8/22/2017)... ... 22, 2017 , ... “Without Love’s Beauty and Pleasures Life ... struggles faced while hoping for a better life. “Without Love’s Beauty and Pleasures ... who spent 13 years working with deprived/neglected adolescents and almost 20 years working ...
(Date:8/22/2017)... ... , ... “Call Of Spiritual Duty”: a revelation in an era defined by ... Growing up on the streets of North Visalia, California, Carlos Lizarde quickly became ... Biblical keys to his life, he noticed immediately that opportunities and blessings began to ...
(Date:8/21/2017)... Los Angeles, California (PRWEB) , ... August 21, ... ... Physicians is announcing the addition of two plastic surgery fellows for academic year ... is designed for candidates who have successfully completed residency in Plastic and Reconstructive ...
Breaking Medicine News(10 mins):